ACTRN12621000538842招募中未知
COVID-19 Vaccine Efficacy in patients with Haematological Malignancy
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Greater than or equal to 18 years of age
- •2. Able to provide voluntary informed consent
- •3. Planned receipt of a COVID19 vaccine of any variety; e.g. Pfizer-BioNTech BNT162b2, AstraZeneca Oxford ChAdOx1 nCoV-19 (AZD1222), Novavax NVX-CoV2373 or ModernaTX mRNA-1273 vaccine.
- •- Patients who have any haematological malignancy and received treatment with a B-cell targeted therapy or who have received a bone marrow transplant may be recruited to Cohort A.
- •- Patients who do not have a diagnosis of a haematological malignancy or any other active cancer, and who have not received treatment with B cell depleting antibodies will be recruited to Cohort B. 50 patients will be recruited in total, 30 to Cohort A and 20 to Cohort B.
排除标准
- •1. Current diagnosis of and/or treatment for a non-haematological malignancy.
- •2. Receipt of B cell targeted therapies for Rheumatological or other non-haematological malignancy indication
- •3. Unable to provide voluntary informed consent
研究者
相似试验
进行中（未招募）
1 期
SARS-CoV-2 vaccination response in patients with haematologicaldiseaseEUCTR2021-001107-33-NLMUMC743
招募中
不适用
Hemostatic changes after COVID-19 vaccination in patients with hematologic malignancy diseasesCancer patients are considered to be at higher risk of thrombosis than the normal population. As previously reported, thromboembolic complications are five times more common among cancer patients than the normal population, with up to 10-15% during the incurable period. Patients with hematologic malignancies also have an increased risk of thromboembolic complications.Hemostatic changes after COVID-19 vaccination in patients with hematologic malignancy diseasesTCTR20211109005Siriraj Hospital Mahidol University400
进行中（未招募）
不适用
Efficacy of COVID-19 Vaccination in People with Follicular Lymphoma and Waldenström Macroglobulinaemia – A Prospective Cohort StudyFollicular LymphomaWaldenstrom MacroglobulinaemiaBlood - Haematological diseasesCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphomaACTRN12621001202853Concord Repatriation General Hospital85
尚未招募
不适用
Vaccine effectiveness in COVID-19CTRI/2021/11/037962Dr Surag MK
进行中（未招募）
1 期
Response to corona vaccination in patients with primary Sjögren's syndromePrimary Sjögren's syndromeEUCTR2021-001414-10-NLniversity Medical Center Groningen180